Showing results (461-470 of 749) with videos related to

Sort By:
Pageof 75
Bioinorganic Chemistry and Applications|March 28, 2008
Gold binding by native and chemically modified hops biomassesM Laura López, J L Gardea-Torresdey, J R Peralta-Videa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 2, 2021
Association between Ideal Cardiovascular Health and aortic stiffness in Italian adolescents. The MACISTE studyGiacomo Pucci, Valeria Bisogni, Francesca Battista, et al.
Oncotarget|October 6, 2017
Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activationStefania Napolitano, Giulia Martini, Erika Martinelli, et al.
Radiation Protection Dosimetry|December 31, 2005
The TRADE experiment: shielding calculations for the building hosting the subcritical systemK W Burn, M Carta, L Casalini, et al.
Clinical Spine Surgery|July 14, 2025
Prevalence of Complications of Patients Treated With Steroids for Acute Subaxial Cervical Spinal Cord InjuriesDavid Kowalski, Ellen Lutnick, Emily K Vallee, et al.
Global Spine Journal|May 23, 2025
Efficacy of Mesenchymal and Embryonic Stem Cell Therapy for the Treatment of Spinal Cord Injury: A Systematic Review and Meta-Analysis of Human StudiesZachary Troiani, Danielle E Chipman, Thomas J Ryan, et al.
World Journal of Clinical Oncology|September 3, 2025
Whole-body magnetic resonance imaging for cutaneous melanoma staging: A scientific reviewAnna Russo, Luca Marinelli, Vittorio Patanè, et al.
BMC Genomics|February 28, 2016
Rapid identification of causative insertions underlying Medicago truncatula Tnt1 mutants defective in symbiotic nitrogen fixation from a forward genetic screen by whole genome sequencingVijaykumar Veerappan, Mehul Jani, Khem Kadel, et al.
Cancer Treatment Reviews|March 13, 2022
Immunotherapy in advanced anal cancer: Is the beginning of a new era?Davide Ciardiello, Luigi Pio Guerrera, Brigida Anna Maiorano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activityGiampaolo Tortora, Rosa Caputo, Vincenzo Damiano, et al.
Pageof 75